Richard Pulik

Richard Pulik is currently serving as the Chief Financial Officer at Roivant Sciences, a company focused on improving healthcare delivery through innovative approaches. Prior to this role, Richard held various positions at Novartis, including Global Head of BD&L and Portfolio Management in Oncology. With a background in finance and economics from The Wharton School and University of Pennsylvania, Richard has also gained experience in investment banking and mergers & acquisitions at Bank of America/Merrill Lynch and UBS Investment Bank.